Novo Settles U.S. Probe of Kickbacks, Disguised Salespeople
Novo Nordisk A/S has agreed to settle a U.S. probe of its marketing of diabetes drugs that allegedly included disguising salespeople as medical educators and paying kickbacks to persuade doctors to prescribe ...